The Robert A. Winn Diversity in Clinical Trials: Career Development Award
administered by the Winn Awards Team at the Virginia Commonwealth University (VCU) Massey Comprehensive Cancer Center
supported by the Bristol Myers Squibb Foundation, Inc.
Unlimited numbers of applicants are permitted per institution.
Summary: This two-year program is designed to support the career development of early-stage investigator physicians who are committed to increasing diversity in clinical trials, preparing them to become independent community-oriented clinical trialists.
Stanford Medicine Cardiovascular Medicine and Cardiovascular Institute Informational Session – March 8, 2024, 4pm PST
CV Med and CVI are excited to co-host an information session covering The Robert A. Winn Diversity in Clinical Trials Award Program - Career Development Award.
Webinar Registration: The Robert A. Winn Diversity in Clinical Trials Award Program - Career Development Award Informational Session
Timeline:
SoM applicants are required to initiate a Proposal Intake Form (PIF) in SeRA approximately one month prior to the internal deadline. Career Development PI Waivers are required for non-faculty.
Institutional representative (RPM/RMG or CGO/OSR) deadline: May 6, 2024
Application Deadline: May 13, 2024
Program Guidelines:
Robert A. Winn Diversity in Clinical Trials: Career Development Award (Winn CDA)
Application Registration and Submission portal
Frequently Asked Questions
Eligibility:
- Must identify in a racial/ethnic group designated as “underrepresented in medicine” OR have a demonstrated commitment to increasing diverse patient participation in clinical trials; See website for more details.
- Must be a US Citizen, Lawful Permanent Resident, or hold a H-1B or O-1 Visa
- Must hold the degree of MD, MD/PhD, DO, or DO/PhD
- Must focus on one of the following clinical research areas: cancer (hematology and oncology), cardiovascular diseases or immunologic disorders
- Must be an early-stage investigator (ESI), as defined by the National Institutes of Health
- Stanford clarification: if a PI does not hold an independent faculty appointment (UTL, UML, NTLR appointment), an approved Career Development PI waiver will be required before the Institutional representative (RPM/RMG or CGO/OSR) deadline.
Program Overview:
The Robert A. Winn Diversity in Clinical Trials: Career Development Award (Winn CDA), supported by the Bristol Myers Squibb Foundation, is a 2-year program designed to support the career development of early-stage investigator (as defined by NIH) physicians from diverse backgrounds, and physicians who have a demonstrated commitment to increasing diversity in clinical research, to become independent clinical trial investigators who are engaged in advancing health equity through their research and mentoring. Currently, our clinical research areas include cancer, cardiovascular disease and immunologic disorders. The Winn CDA offers a comprehensive and integrated approach to increasing diversity in clinical trials through workforce development and mentoring.
Amount of Funding:
The Winn CDA provides $120,000 annually for two years to institutions sponsoring scholars. The funds are expected to cover a percentage of each scholar’s salary, equivalent to 40% of their time. Scholars are required to receive mentorship from a seasoned clinical investigator at a clinical trial site or institution and are expected to actively participate in their mentor’s clinical trial, which must meet the FDA Clinical Trial Definition. Scholars aren’t expected to run their own trials. The allowable indirect cost rate is 10%.
Questions? The Program is administered by the Winn Awards Team at the VCU Massey Cancer Center.
For general inquiries, please contact us at WinnAwardInfo@vcu.edu.
For inquiries related to the Robert A. Winn Career Development Award (Winn CDA), please contact us at WinnCDA@vcu.edu.